| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/17/1994 | WO1994003437A1 Benzodiazepine derivatives |
| 02/17/1994 | WO1994003427A1 2-thioindoles (selenoindoles) and related disulfides (selenides) which inhibit protein tyrosine kinases and which have antitumor properties |
| 02/17/1994 | WO1994003205A1 Hla binding peptides and their uses |
| 02/17/1994 | WO1994003200A1 Morphogen-induced nerve regeneration and repair |
| 02/17/1994 | WO1994003197A1 Pharmaceuticals containing onconase and cisplatin, melphalan and adriamycin |
| 02/17/1994 | WO1994003196A1 New tumor diagnosing or therapeutical probe |
| 02/17/1994 | WO1994003183A1 Medicinal composition for inhibiting cancer metastasis to liver and medicinal composition for curing hepatoma |
| 02/17/1994 | WO1994003178A1 Therapeutic use of phosphoryl-l-serine-n-acyl-sphingosine |
| 02/17/1994 | WO1994003163A1 Use of 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone for the treatment of cancer |
| 02/17/1994 | CA2142185A1 Inhibitors of cell proliferation, their preparation and use |
| 02/17/1994 | CA2141960A1 Hla binding peptides and their uses |
| 02/17/1994 | CA2141847A1 Ptp-d subfamily of protein tyrosine phosphatases |
| 02/17/1994 | CA2141678A1 New tumor diagnosing or therapeutical probe |
| 02/17/1994 | CA2141557A1 Therapeutic use of phosphoryl-l-serine-n-acyl-sphingosine |
| 02/17/1994 | CA2141274A1 Use of 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1, 4- naphthoquinone for the treatment of cancer |
| 02/17/1994 | CA2141061A1 Peptides inhibiting ras protein activity, preparation and use thereof |
| 02/17/1994 | CA2140762A1 Pharmaceutical compositions for preventing liver metastasis of cancer and pharmaceutical composition for the treatment of liver cancer |
| 02/17/1994 | CA2140440A1 2-thioindoles (selenoindoles) and related disulfides (selenides) which inhibit protein tyrosine kinases and which have antitumor properties |
| 02/17/1994 | CA2140009A1 Benzodiazepine derivatives |
| 02/17/1994 | CA2120343A1 Fluorinated 17.beta.-substituted 4-aza-5.alpha.-androstan-3-one derivatives |
| 02/16/1994 | EP0583050A2 Recombinant stimulating factor of the neu receptor |
| 02/16/1994 | EP0582581A1 1-SUBSTITUTED, 2-SUBSTITUTED 1H-IMIDAZO 4,5-c]QUINOLIN-4-AMINES |
| 02/16/1994 | CN1082027A 异羟肟酸衍生物 Hydroxamic acid derivatives |
| 02/16/1994 | CN1081909A Methods and compositions for the treatment of diseases with interferon while reducing side effects |
| 02/16/1994 | CN1023804C Novel acetylenic, cyano and allenic aristeromycin/adenosine derivatives |
| 02/15/1994 | US5286850 Antibody DTPA-type ligand conjugates |
| 02/15/1994 | US5286737 Benzyl, cyclopentane azole derivatives |
| 02/15/1994 | US5286726 Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases |
| 02/15/1994 | US5286717 Inhibitors for replication of retroviruses and for the expression of oncogene products |
| 02/15/1994 | US5286716 Inhibitor of the proliferation of endothelial cells |
| 02/15/1994 | CA1327051C Enhancing drug delivery to the brain |
| 02/15/1994 | CA1327047C Complexes of tellurium and selenium derivatives |
| 02/15/1994 | CA1327046C Tellurium and selenium compounds for the induction of in vivo and in vitro production of cytokines |
| 02/15/1994 | CA1327038C Anticancer compounds |
| 02/15/1994 | CA1327037C Mitomycin derivatives having reduced bone marrow toxicity, processes for their preparation, and the uses thereof |
| 02/15/1994 | CA1326996C Preparing process of physiologically active substance with anticancer effect and substance obtained thereby |
| 02/10/1994 | DE4225569A1 Neue Sonde zur Tumordiagnostik oder Tumortherapie New probe for tumor diagnosis and tumor therapy |
| 02/09/1994 | EP0582318A1 Use of carnosic acid for its anticarcinogenic and antiviral properties |
| 02/09/1994 | EP0581954A1 USE OF -g(a)-HYDROXYKETOALKYL DERIVATIVES AS PROTECTIVE LIGHT FILTERS. |
| 02/09/1994 | EP0581848A1 Closed sense and antisense oligonucleotides and uses thereof |
| 02/09/1994 | EP0581803A1 Compositions and methods of treatment of a variety of disorders utilizing etianate and agonists thereof |
| 02/09/1994 | CN1081715A Stem cell proliferation factor |
| 02/09/1994 | CN1023700C Aromatic and heterocyclic carboxamide derivatives as antineoplastic agent and preparation method thereof |
| 02/08/1994 | US5284967 For treating swine |
| 02/08/1994 | US5284937 Antivirals, antitumor agents and immunomodulators |
| 02/08/1994 | US5284868 Naphthopyran derivatives; for autoimmune diseases, cancer |
| 02/08/1994 | US5284865 Antitumor and antileukemia agents |
| 02/08/1994 | US5284864 Antitumor and antileukemia agents |
| 02/08/1994 | US5284831 Boron neutron capture therapy |
| 02/08/1994 | US5284755 DNA encoding leukemia inhibitory factor receptors |
| 02/08/1994 | CA1326849C Treatment of malignant tumors with 8 chloroadenosine 3',5'-cyclic phosphate, and preparation thereof |
| 02/06/1994 | CA2101868A1 Granulocyte-binding antibody constructs, their preparation and use |
| 02/03/1994 | WO1994002633A1 Diagnostic method |
| 02/03/1994 | WO1994002499A1 Oligonucleotide alkylphosphonothioates |
| 02/03/1994 | WO1994002498A1 Hybrid oligonucleotide phosphorothioates |
| 02/03/1994 | WO1994002485A1 Rapamycin derivatives |
| 02/03/1994 | WO1994002483A1 Tetracyclic compounds process and intermediates for their preparation and their use as antitumour agents |
| 02/03/1994 | WO1994002450A1 Amino acid linked nitrogen mustard derivatives and their use as prodrugs in the treatment of tumours |
| 02/03/1994 | WO1994002448A1 Hydroxamic acid derivatives and their use as anti-inflammatory compounds |
| 02/03/1994 | WO1994002447A1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 02/03/1994 | WO1994002446A1 Natural amino acid derivatives as metalloproteinase inhibitors |
| 02/03/1994 | WO1994002445A1 Non-peptidic surrogates of the ldv sequence and their use in the treatment of inflammation, autoimmune diseases and tumour progression |
| 02/03/1994 | WO1994002167A1 p53 VACCINE |
| 02/03/1994 | WO1994002162A1 Peptide medicaments for treating disease |
| 02/03/1994 | WO1994002137A1 Rapamycin derivatives |
| 02/03/1994 | WO1994002136A1 Rapamycin derivatives |
| 02/03/1994 | WO1994002108A1 Chemotherapy for cancer |
| 02/03/1994 | WO1994002106A1 Therapeutic and diagnostic use of modified polymeric microcapsules |
| 02/03/1994 | WO1994002068A1 System of drug delivery to the lymphatic tissues |
| 02/03/1994 | WO1993024096A3 Use of n-(2-(dimethylamino)ethyl)acridine-4-carboxamide and its analogues for cancer treatment |
| 02/03/1994 | WO1993010741A3 Sex steroid activity inhibitors |
| 02/03/1994 | CA2141214A1 Hydroxamic acid derivatives and their use as anti-inflammatory compounds |
| 02/03/1994 | CA2140931A1 Non-peptidic surrogates of the ldv sequence and their use in the treatment of inflammation, autoimmune disease and tumour progression |
| 02/03/1994 | CA2140662A1 Tetracyclic compounds, process and intermediates for their preparation and their use as antitumour agents |
| 02/03/1994 | CA2140542A1 Oligonucleotide alkylphosphonothioates |
| 02/03/1994 | CA2140333A1 Therapeutic and diagnostic use of modified polymeric microcapsules |
| 02/03/1994 | CA2140033A1 Peptide medicaments for treating disease |
| 02/03/1994 | CA2139410A1 Diagnostic method |
| 02/02/1994 | EP0581108A2 Bispecific antibody reactive with sialyl-Lea antigen and CD3 |
| 02/02/1994 | EP0580968A2 Vitamin D3 fluorinated analogs |
| 02/02/1994 | EP0580829A1 Bacterial protein extract, process for preparing the same and pharmaceutical composition containing said extract |
| 02/02/1994 | EP0580812A1 Anti-tumor and anti-psoriatic agents |
| 02/02/1994 | EP0580795A1 Antisense oligonucleotides to c-kit proto-oncogene and uses thereof |
| 02/02/1994 | EP0580790A1 Method for potentiating primary drugs in treating multidrug resistant cells |
| 02/02/1994 | EP0580774A1 Vitamin d derivatives comprising a lateral chain expoxide group |
| 02/02/1994 | EP0580754A1 Oligodeoxynucleotides and oligonucleotides useful as decoys for proteins which selectively bind to defined dna sequences |
| 02/02/1994 | EP0580609A1 Pharmaceutical xanthone derivatives |
| 02/02/1994 | EP0580598A1 Styryl-substituted heteroaryl compounds which inhibit egf receptor tyrosine kinase |
| 02/02/1994 | EP0580594A1 New inhibitors of endothelial cell proliferation |
| 02/02/1994 | EP0450021B1 Anti-cancer compounds |
| 02/02/1994 | EP0432209B1 Phenylpyrrolic compounds used as drugs, their preparation and application |
| 02/01/1994 | US5283383 Antitumor compound, compositions and method of use |
| 02/01/1994 | US5283253 Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them |
| 02/01/1994 | US5283238 Methods of treating cancer using modified C-reactive protein |
| 02/01/1994 | CA1326675C Trienic derivatives with a chromenic structure, their processes of preparation and pharmaceutical compositions containing them |
| 02/01/1994 | CA1326674C Heteroarotinoid derivatives, their processes of preparation and pharmaceutical compositions containing them |
| 01/28/1994 | CA2481077A1 Beta-alethine use in cell culture and therapy |
| 01/26/1994 | EP0580459A1 Substituted Phenylimidazolidins, process for their preparation, their use as medicaments and their pharmaceutical compositions containing them |
| 01/26/1994 | EP0580008A2 Phenylimidazolidine Derivatives, their preparation and use |
| 01/26/1994 | EP0579939A1 Phospholipid derivatives |